142 related articles for article (PubMed ID: 8208366)
1. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia.
Syversen U; Jacobsen MB; O'Connor DT; Rønning K; Waldum HL
Neuropeptides; 1994 Mar; 26(3):201-6. PubMed ID: 8208366
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies.
Syversen U; Opsjøn SL; Stridsberg M; Sandvik AK; Dimaline R; Tingulstad S; Arntzen KJ; Brenna E; Waldum HL
J Clin Endocrinol Metab; 1996 Dec; 81(12):4470-5. PubMed ID: 8954061
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.
Syversen U; Mignon M; Bonfils S; Kristensen A; Waldum HL
Acta Oncol; 1993; 32(2):161-5. PubMed ID: 8323758
[TBL] [Abstract][Full Text] [Related]
5. Distribution and coexistence of chromogranin A-, serotonin- and pancreastatin-like immunoreactivity in endocrine-like cells of the human anal canal.
Hörsch D; Weihe E; Müller S; Hancke E
Cell Tissue Res; 1992 Apr; 268(1):109-16. PubMed ID: 1499046
[TBL] [Abstract][Full Text] [Related]
6. Phylogenetic aspects of pancreastatin- and chromogranin-like immunoreactive cells in the gastro-entero-pancreatic neuroendocrine system of vertebrates.
Reinecke M; Höög A; Ostenson CG; Efendic S; Grimelius L; Falkmer S
Gen Comp Endocrinol; 1991 Aug; 83(2):167-82. PubMed ID: 1916205
[TBL] [Abstract][Full Text] [Related]
7. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension.
Sánchez-Margalet V; Valle M; Lobón JA; Escobar-Jiménez F; Pérez-Cano R; Goberna R
Neuropeptides; 1995 Aug; 29(2):97-101. PubMed ID: 7477767
[TBL] [Abstract][Full Text] [Related]
8. The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system.
Bishop AE; Bretherton-Watt D; Hamid QA; Fahey M; Shepherd N; Valentino K; Tatemoto K; Ghatei MA; Bloom SR; Polak JM
Mol Cell Probes; 1988 Sep; 2(3):225-35. PubMed ID: 2851738
[TBL] [Abstract][Full Text] [Related]
9. Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor.
Tateishi K; Kitayama N; Matsuoka Y; Funakoshi A
Life Sci; 1995; 57(9):889-95. PubMed ID: 7630318
[TBL] [Abstract][Full Text] [Related]
10. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M
Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994
[TBL] [Abstract][Full Text] [Related]
11. A phylogenetic survey of pancreastatin and chromogranin immunoreactivity in chromaffin (TH-, DBH-, and PNMT-immunoreactive) cells of the adrenal organ of vertebrates.
Reinecke M; Maake C
Gen Comp Endocrinol; 1993 May; 90(2):251-65. PubMed ID: 8100544
[TBL] [Abstract][Full Text] [Related]
12. Pancreastatin-like immunoreactivity in epidermal Merkel cells of pig and man.
Hartschuh W; Weihe E
Neurosci Lett; 1989 Apr; 98(3):258-63. PubMed ID: 2657502
[TBL] [Abstract][Full Text] [Related]
13. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
14. Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors.
Ferrari L; Seregni E; Lucignani G; Bajetta E; Martinetti A; Aliberti G; Pallotti F; Procopio G; Della Torre S; Luksch R; Bombardieri E
Int J Biol Markers; 2004; 19(4):295-304. PubMed ID: 15646836
[TBL] [Abstract][Full Text] [Related]
15. Regulation of pancreastatin release from a human pancreatic carcinoid cell line in vitro.
Jeng YJ; Townsend CM; Nagasawa S; Chuo S; Kern K; Yanaihara N; Ferrar RS; Hill FL; Thompson JC; Greeley GH
Endocrinology; 1991 Jan; 128(1):220-5. PubMed ID: 1702700
[TBL] [Abstract][Full Text] [Related]
16. Prohormone convertase-1 is essential for conversion of chromogranin A to pancreastatin.
Udupi V; Lee HM; Kurosky A; Greeley GH
Regul Pept; 1999 Sep; 83(2-3):123-7. PubMed ID: 10511466
[TBL] [Abstract][Full Text] [Related]
17. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A.
Schmidt WE; Siegel EG; Kratzin H; Creutzfeldt W
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8231-5. PubMed ID: 3186720
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries.
Lloyd RV; Jin L; Qian X; Scheithauer BW; Young WF; Davis DH
Am J Pathol; 1995 May; 146(5):1188-98. PubMed ID: 7747813
[TBL] [Abstract][Full Text] [Related]
19. Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors.
Yasuda D; Iguchi H; Funakoshi A; Wakasugi H; Sekiya K; Misawa T; Tateishi K; Bloom SR; Nawata H
Horm Metab Res; 1993 Nov; 25(11):593-5. PubMed ID: 8288164
[TBL] [Abstract][Full Text] [Related]
20. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues.
Schmidt WE; Siegel EG; Lamberts R; Gallwitz B; Creutzfeldt W
Endocrinology; 1988 Sep; 123(3):1395-404. PubMed ID: 3042370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
